BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20040254)

  • 1. Interferon induced sarcoidosis with cutaneous involvement along lines of venous drainage in a former intravenous drug user.
    Shuja F; Kavoussi SC; Mir MR; Jogi RP; Rosen T
    Dermatol Online J; 2009 Dec; 15(12):4. PubMed ID: 20040254
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
    Bruch-Gerharz D; Reifenberger J
    Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cutaneopulmonary sarcoidosis during pegylated interferon plus ribavirin therapy].
    Sánchez-Ruano JJ; Artaza-Varasa T; Gómez-Rodríguez R; González de Frutos C; Repiso-Ortega A; Alcántara-Torres M
    Gastroenterol Hepatol; 2006 Mar; 29(3):150. PubMed ID: 16507282
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
    López V; Molina I; Monteagudo C; Jordá E
    Int J Dermatol; 2011 Mar; 50(3):287-91. PubMed ID: 21342161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications.
    Zampino MR; Corazza M; Borghi A; Marzola A; Virgili A
    Acta Derm Venereol; 2009 Nov; 89(6):661-2. PubMed ID: 19997710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].
    Waltschew A
    Pathologe; 2016 Mar; 37(2):184-6. PubMed ID: 26769217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
    Honsová E; Sticová E; Sperl J
    Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis.
    Buss G; Cattin V; Spring P; Malinverni R; Gilliet M
    Dermatology; 2013; 226(4):289-97. PubMed ID: 23886768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sarcoidosis associated with the treatment of hepatitis C: case report and Spanish literature review].
    Trullàs JC; Hernández-Marcet P; Bisbe J
    Med Clin (Barc); 2011 May; 136(14):649-50. PubMed ID: 21051060
    [No Abstract]   [Full Text] [Related]  

  • 11. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
    Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
    Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
    [No Abstract]   [Full Text] [Related]  

  • 12. Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
    Guilabert A; Bosch X; Julià M; Iranzo P; Mascaró JM
    Br J Dermatol; 2005 Feb; 152(2):377-9. PubMed ID: 15727663
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarcoidosis or foreign-body granulomatous reaction during interferon treatment?
    Bitetto D; Fumolo E; Fabris C; Toniutto P
    Liver Int; 2010 Aug; 30(7):1083-4; author reply 1084. PubMed ID: 20214737
    [No Abstract]   [Full Text] [Related]  

  • 14. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C.
    Chiang CH; Lai FJ
    J Formos Med Assoc; 2014 Dec; 113(12):981-2. PubMed ID: 25187070
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
    Neglia V; Sookoian S; Herrera M; Abeldaño A; Kien MC; Chouela E; Frider B
    J Cutan Med Surg; 2001; 5(5):406-8. PubMed ID: 11915769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis caused by interferon therapy.
    Celik G; Sen E; Ulger AF; Kumbasar OO; Bozkaya H; Alper D; Karayalcin S
    Respirology; 2005 Sep; 10(4):535-40. PubMed ID: 16135181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoidosis developing after treatment with interferon alpha in a patient with hepatitis C: An association every physician should know.
    Flores-Robles BJ; Sangüesa-Gómez CP; Barbadillo Mateos C; Roustán-Gullón LG; Kovtun I
    Rev Gastroenterol Mex; 2017; 82(2):185-186. PubMed ID: 27161792
    [No Abstract]   [Full Text] [Related]  

  • 18. Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C.
    Yan KK; Dinihan I; Freiman J; Zekry A
    Intern Med J; 2008 Mar; 38(3):207-10. PubMed ID: 18290816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases.
    Descamps V; Landry J; Francès C; Marinho E; Ratziu V; Chosidow O
    Dermatology; 2008; 217(1):81-4. PubMed ID: 18446029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM; Davis C; Olerud J
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.